F.D.A. Rejects Closely Watched Lung Cancer Drug From China
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
Read the original story ↗Latest financial headlines and short publisher introductions. Follow the source link to read the full story.
Showing 1–1 of 1 stories
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
Read the original story ↗Headlines and short introductions belong to the identified publishers. Full stories open on their original sites and may require a subscription. For informational and educational purposes.